Second messenger up-regulation of androgen receptor gene transcription is absent in androgen insensitive human prostatic carcinoma cell lines, PC-3 and DU-145  by Stubbs, A.P. et al.
FEBS 16855 FEBS Letters 383 (1996) 237-240 
Second messenger up-regulation of androgen receptor gene transcription 
is absent in androgen insensitive human prostatic carcinoma cell lines, 
PC-3 and DU-145 
A.P. Stubbs a'b, E.-N. LalanP,*, G.W.H. Stamp ~, H. Hursff, P. Abel d, J. Waxman b
aDepartment ofHistopathology, Royal Postgraduate Medical School Hammersmith Hospital, Du Cane Road, London W12 ONN, UK 
bDepartment of Oncology, Royal Postgraduate Medical School Hammersmith Hospital, Du Cane Road, London W12 ONN, UK 
CDepartment of ICRF Oncology Unit, Royal Postgraduate Medical School Harnmersmith Hospital, Du Cane Road, London W12 ONN, UK 
d Department ~ Surgery, Royal Postgraduate Medical School Hammersmith Hospital Du Cane Road, London W12 ONN, UK 
Received 6 February 1996 
Abstract A theoretical pathway of transcriptional regulation of 
the androgen receptor (AR) gene is via a cAMP response lement 
(CRE) present in its promoter egion ( -508 to -501). After 20 h 
of stimulation with 8-bromo-cAMP, AR mRNA was upregulated 
in LNCaP but not in either PC-3 or DU-145 cell lines. We have 
demonstrated that the level of CRE binding protein (CREB) was 
the same in all cell lines and that the putative AR-CRE forms 
specific and competable protein interactions with CREB. The 
ability to regulate AR gene transcription via the second 
messenger pathway is lost in the PC-3 and DU-145 cell lines. 
This may be an important primary mechanism of androgen 
insensitivity in prostate cancer. 
Aey words: Androgen receptor; Electromobility shift assay; 
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1 Introduction 
determine whether the putative CRE located in the AR gene 
promoter ( -508 to -501)  functioned as a known CRE. 
Our results show that the AR/CRE forms specific and com- 
petable protein interactions with cAMP response element 
binding protein (CREB) as compared with a known CRE 
sequence from adenovirus E4 promoter. In AR positive cells 
(LNCaP), AR mRNA is upregulated in the presence of 5 mM 
8-bromo-cAMP but this induction is lost in the AR negative 
cell lines DU-145 and PC-3. The protein specific interactions 
of the AR/CRE sequence in the three prostatic cell lines were 
demonstrated by an electromobility shift assay (EMSA). Our 
results demonstrate that levels of CREB specific AR/CRE 
interactions in all three cell lines are similar. Furthermore, 
the lack of AR  mRNA induction in DU-145 and PC-3 with 
8-bromo-cAMP does not occur at the level of the CREB 
transcription factor. This may be an important primary mech- 
anism of androgen insensitivity in prostate cancer. 
Prostate cancer is the most common malignancy and the 
second commonest cause of death from cancer in men [1]. 
q he growth and differentiation of the normal prostate gland 
iF dependent on androgen stimulation. It is observed that 
a though 70-80% of prostate cancers are initially responsive 
t~ androgen deprivation therapies, progression to an andro- 
gen-insensitive state occurs and the tumour becomes refrac- 
t,,ry to treatment [2]. The mechanism underlying this switch 
fl om androgen sensitivity (AS) to insensitivity (AI) is poorly 
understood. Although androgens are regulated via the AR 
n Lost prostatic carcinomas even in the hormone insensitive 
s~age contain a structurally intact AR  with retained androgen 
binding capacity [3]. 
Potential mechanisms postulated for the change from AS to 
/, I involve mutations in the AR coding region [4], amplifica- 
ton  of th AR gene [5], and mutations in the AR gene pro- 
r toter, although the latter has not been explored. A point 
~tutation in the hormone binding domain (codon 877, exon 
~'1 has been associated with metastatic prostate cancer [6]. 
l [owever, such genetic alterations are rare and inconsistent 
and would not explain the observed frequency of the emer- 
gznce of AI in human tumours. 
The aim of our study was to stimulate AR gene transcrip- 
tion in androgen sensitive and insensitive prostatic arcinoma 
c.Als using a stable cAMP analogue, 8-bromo-cAMP and to 
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2. Materials and methods 
All chemicals were of the highest purity and purchased from Sigma 
chemicals unless otherwise stated. 
2.1. Cell culture 
LNCaP, PC-3 and DU-145 cell lines were routinely cultured in 
Dulbecco's modified Eagles medium without phenol red (DMEM- 
woPR) supplemented with 10% fetal bovine serum (FBS) (Gibco 
BRL). Cells were plated at a concentration of 105 cells per 25 cm 2 
tissue culture flask. After 24 h the culture medium was replaced with 
either fresh medium or with DMEMwoPR supplemented with 10% 
charcoal stripped FBS (CSFBS) and cultured for a further 48 h (to 
80°/'0 confluence). The cells were then either stimulated with 8-bromo- 
cAMP (5 mM) or maintained under the same culture conditions for a 
further 20 h. 
2.2. Reverse transcriptase-polymerase chain reaction (RT-PCR) 
RNA was extracted by the RNAzol B method (Biogenesis Ltd, 
UK). Briefly, cells were washed twice with phosphate-buffered saline 
(PBS) pH 7.2 7.4 and lysed directly in the flask with 2 ml of RNAzol 
B. Chloroform was added to supernatant (1/10 of the volume) and the 
mixture vortexed for 15 s followed by centrifugation at 13 000 × g for 
15 min at 4°C (MSE MicroCentur). The aqueous phase was removed 
and RNA precipitated with an equal volume of isopropanol and cen- 
trifuged for a further 15 min at the same temperature and speed. The 
resultant RNA pellet was washed with 75% ethanol, dried at 65°C in a 
heating block for 5 min and then resuspended in diethyl pyrocarbo- 
nate (DEPC)-treated water. Total RNA (2 p.g) was denatured at 70°C 
for l0 min and chilled on ice for 2 min. cDNA was synthesised from 
2 Ixg of denatured RNA in 50 mM Tris-C1 pH 8.3, 75 mM KCI, 10 
mM dithiothreitol, 3 mM MgCl2 (Gibco BRL), 40 U RNAsin (ribo- 
nuclease inhibitor, Promega), 500 IxM dNTPs (Promega), 1 ml 
oligo(dT)i2_ls (Gibco BRL) and 50 U of StrataScriptase (Statagene) 
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Table 1 
Double-stranded DNA sequences used for electromobility shift assay 
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E4/CRE 
AR/CRE 
5'-T T C C GT  T A C G T C A T T T T T T A G-3 '  
3 ' -GGC A A T G C A G T A AAA A AT  C T T -5' 
5 ' -GA T C T C C C T A T G A C G G A A T C T AA  G-3 '  
3'-A GGGA T A C T G C C T T A GA T T C C T A G-5 '  
Underlined sequence represents CREB specific region. 
in a final volume of 20 lal. This mixture was incubated at 37°C for 1 h 
and the resultant RNA/cDNA was stored at -20°C until use. 
PCR for both AR and glyceraldehyde phosphate dehydrogenase 
(GAPDH) consisted of 100 ng cDNA, 10 mM Tris-C1 (pH 9), 50 
mM KCI, 0.01% gelatin w/v, Triton X-100 (Promega), 5 p~M of 
each primer either AR specific [7] (forward primer 5'-AGC- 
TACTCCGGACCTTACG-Y and reverse primer 5'-AGGTGC- 
CATGGGAGGGTTAG-Y) or GAPDH specific [8] (forward primer 
5'-GCCACATCGCTCAGACACCA-Y and reverse primer 5'-GAT- 
GACCCTTTTGGCTCCCC-3'), 200 laM dNTPs (Promega), 1.5 mM 
MgCI2 and 1.5 U Taq polymerase (Promega) in a final volume of 25 
I11. Thermal cycling parameters for AR were 94°C for 1 min, 60°C for 
1 min, 72°C for 3 min with a final extension of 72°C for 10 min, for, 
20, 25, 30 or 35 cycles, and GAPDH were 940C for 1 min, 65°C for 
1 min and 72°C for 3 min for 15, 20, 25 or 30 cycles in a Techne- 
PHC3 thermal cycler. PCR products were separated on either a 1% or 
1.5% TAE-agarose gel and visualised with ethidium bromide (0.5 mg/ 
ml). Bands migrating at the predicted size of AR (1.4 kb) or GAPDH 
(483 bp) were gel purified using the Wizard PCR Preps (Promega) and 
sequenced with the fmol Sequencing System (Promega). 
2.3. Nuclear extracts 
Cells were harvested and washed twice in PBS then resuspended in 
300 ml of lysis buffer (20 mM Tris-Cl pH 8, 20 mM NaCI, 0.5% 
Nonidet NP-40 (v/v), 20% sucrose (v/v), 2 mM DTT and 0.5 mM 
PMSF) and incubated on ice for 10 min then centrifuged at 
13 000 x g for 1 min at 4°C. The resultant nuclear pellet was resus- 
pended in 100 ml extraction buffer (20 mM Hepes pH 7.9, 0.45 M 
KC1, 1.5 mM MgC12, 0.2 mM EDTA, 25% glycerol (vol/vol), 2 mM 
DTT and 0.5 mM PMSF) and left on ice for 30 min followed by 
centrifugation at 13000xg for 1 min at 4°C. The final supernatant 
was aliquoted and stored at -70°C. The protein concentration was 
determined using the BioRad protein assay kit with bovine serum 
albumin as a standard. 
2.4. Electromobility shift assay (EMSA) 
Nuclear extracts (1-2 lag) were incubated for 2 h at 4°C in the 
presence or absence of an anti-CREB antibody followed by a further 
20 min at room temperature with either 0.1 ng of 32P-end-labelled 
adenovirus ATF-2 sequence [9] (Table 1) or 17.5 pM 32P-end-labelled 
AR/CRE (Table 1) dsDNA, in a gel retardation assay buffer (25 mM 
Hepes pH 7.9, 0.15 M NaC1, 1 mM EDTA, 2 mM DTT, 10% glycerol 
(v/v), 1 lag of poly(dI-dC), 350 pM unrelated 30 bp dsDNA) with or 
without unlabelled specific probe (E4/CRE or AR/CRE). Products 
were separated on a 4% acrylamide gel (80:1 acrylamide:bisacryla- 
mide, 0.5×TBE, 2.5% glyercol v/v) in 0.5XTBE (10XTBE: 890 
mM Tris, 890 mM boric acid, 20 mM EDTA pH 8) transferred to 
Whatman 3MM paper, dried and exposed at -70°C overnight o 
Kodak X-OMAT film. 
3. Results 
The presence of AR transcription in LNCaP was demon- 
strated by an appropriate 1.4 kb PCR product and verifica- 
tion of specificity was achieved by sequence analysis by the 
fmol Sequencing System (Promega, UK). Standardisation of 
the semiquantitative PCR determination of AR and GAPDH 
mRNA expression was determined by repeating PCR thermal 
cycling for 20, 25, 30 and 35 cycles (for AR) or 15, 20, 25 and 
30 cycles (for GAPDH).  Linearity for AR  PCR was achieved 
at 25 cycles (Fig. 1) and for GAPDH after 15 cycles (data not 
shown). Fig. 1 represents the results of AR  PCR amplification 
of samples 1-4 (with FBS), 5-8 (with CSFBS) and 9-12 
(CSFBS and 5 mM 8-bromo-cAMP) for 20 (1,5,9), 25 
(2,6,10), 30 (3,7,11) and 35 (4,8,12) cycles. It is clear that 
the expression of AR  mRNA is reduced in the presence of 
FBS (1-4) as compared to those cultured with CSFBS (5-8) 
or stimulated with 8-bromo-cAMP (9-12). GAPDH expres- 
sion was the same under all experimental conditions. 
To examine the ability of the putative AR/CRE to form 
specific DNA-protein complexes, an electromobility shift as- 
sasy was performed using nuclear extracts from Hela cells, 
CREB protein produced from rabbit reticulolysate and a 
known CRE from adenovirus (Fig. 2). In the absence of 
CREB specific antibody (lanes 2,6) a single major band was 
observed with both the E4 and AR/CRE sequence (labelled B) 
both of which were abolished by a 20-fold excess of unlabelled 
E4 or AR/CRE (lanes 3 and 7, respectively). In the presence 
of a CREB specific antibody (Fig. 2, lanes 1,4,8) two specific 
bands were observed (A,C). Band A was competed out with 
either a 20-fold excess of unlabelled E4 (lane 5) or AR/CRE 
(lane 9) whereas band C remained unchanged uring the same 
competition. Using CREB protein produced in a rabbit reti- 
culolysate, it is clear that band A represents CREB specific- 
DNA interactions (Fig. 2, lane 1). This experiment demon- 
M 1 2 3 4 5 6 7 8 9 10 11 12 
1.4 
20 35 20 35 20 35 
Fig. 1. Expression of AR mRNA in LNCaP cells. PCR was performed on total RNA as described in the text and the products were resolved 
on a 1% TAE agarose gel. Levels of AR mRNA in the presence of: (lanes 1~,) FBS, (lanes 5-8) SCFBS, (lanes 9-12) SCFBS+5 mM 8-bro- 
mo-cAMP, and (lane M) 100 bp ladder. Numbers 2(~35 refer to PCR cycle number. 
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strates that the AR/CRE forms specific competable DNA in- 
teractions with CREB which are comparable to a known CRE 
[91. 
EMSA was used to identify the protein specific interaction 
of this AR/CRE sequence in these prostatic ell lines. Lack of 
second messenger stimulation in PC-3 and DU-145 may be 
dte to the inability of the cells to form AR/CRE-CREB com- 
plexes. In Fig. 3 CREB specific interactions (band A) with 
Hela cell extracts (lane 1) are compared with those from the 
L'qCaP cell line in the absence of CREB specific antibody 
(Lnes 2) and in the presence of CREB specific antibody 
(llne 3-5). CREB-AR/CRE was competed out with 20-(lane 
4) and 100-fold (lane 5) excess of unlabelled AR/CRE. The 
p~esence of this protein-AR/CRE interaction was identified in 
LNCaP (Fig. 4), DU-145 and PC-3. The levels of these pro- 
te n-DNA interactions in LNCaP cells are similar under dif- 
fe:ent experimental culture conditions of FBS (lanes 2,3), 
S~;FBS (lanes 4,5) and SCFBS with 5 mM 8-bromo-cAMP 
(lanes 6,7). The levels of CREB specific interactions in both 
D U-145 and PC-3 (data not shown) were similar in all experi- 
rv total conditions tudied. 
4. Discussion 
To understand the mechanism by which androgen insensi- 
ti ,ity occurs in prostate cancer, we have analysed the regula- 
t im of the human AR transcription i both androgen sensi- 
ti ,e (LNCaP) and insensitive (DU-145 and PC-3) cell lines. 
1 2 3 4 5 6 7 8 9 
1 2 3 4 5 
[ g. 2. EMSA of nuclear extracts from Hela cells and CREB pro- 
ttin produced from rabbit reticulolysate (RL). (Lane 1) CREB 
(RL), (lanes 2 9) Hela nuclear extract, (lanes 1,4,5,8,9) CREB speci- 
fi: antibody, (lanes 1 5) E4/CRE, (lanes 6-9) AR/CRE. Band B re- 
wesents pecific binding to both E4/CRE and AR/CRE in the ab- 
sence of CREB specific antibody and band A, CREB specific 
ir~teractions with both E4/CRE and AR/CRE. 
Fig. 3. EMSA of LNCaP nuclear extract with AR/CRE. (Lane 1) 
Control (Hela), (lanes 2-5) LNCaP, (lanes 1,3-5) with anti-CREB 
antibody, (lanes 4,5) with 20x and 100x AR/CRE. Band A repre- 
sents CREB specific interaction. 
Based on sequence homology the AR promoter egion con- 
tains a putative cAMP response lement (located at -508 to 
-501). 
We were able to demonstrate upregulation of AR gene 
transcription i the presence of charcoal-stripped fetal bovine 
serum and 8-bromo-cAMP (5 mM). Charcoal stripping results 
in the removal of factors such as steroids which inhibit AR 
mRNA levels and thus the results represent a true measure of 
the effect of cAMP and cAMP analogues on AR gene tran- 
scription. Although previous reports have demonstrated a 2- 
fold induction of AR mRNA with 5 mM (Bu)2cAMP [10] we 
were unable to detect AR mRNA expression i  DU-145 and 
240 A.P. Stubbs et al./FEBS Letters 383 (1996) 237 240 
1 2 3 4 5 6 7 
A. 
Fig. 4. EMSA of CREB specific LNCaP nuclear extract with AR/ 
CRE. (Lane 1) Control (Hela), (lanes 2-7) LNCaP, (lanes 2,3) FBS, 
(lanes 4,5) SCFBS, (lanes 6,7) SCFBS+5 mM 8-bromo-cAMP. Band 
A represents CREB specific interaction. 
PC-3 either before or after stimulation with 8-bromo-cAMP 
even after 40 cycles of PCR amplification. This lack of induc- 
tion is not due to gene deletion (data not shown). 
To examine the molecular basis for the loss of cAMP in- 
duced AR transcription we have characterised the putative 
AR/CRE (-508 to -501) with a known CRE (E4/CRE), 
the ATF-2 site at -50  from the adenovirus E4 promoter [9]. 
Specific competable protein-DNA interactions were observed 
between Hela cell nuclear extracts (HCNE) and the E4/CRE 
as compared with the AR/CRE (Fig. 2). A further control of 
CREB synthesised from a rabbit reticulolysate was used to 
verify the specificity of these protein-DNA interactions (Fig. 
2). In addition CREB specific interactions with AR/CRE were 
observed with nuclear extracts isolated from LNCaP (LCNE) 
cells which were comparable to those of the control HCNE. 
Mizokami and colleagues have suggested that protein-AR/ 
CRE interactions with HCNE were different from those 
from LCNE [10], their interpretation being subjective as no 
antibodies were used in the EMSA. The presence of CREB 
specific proteins was also observed in both PC-3 and DU-145 
nuclear extracts and their levels were comparable to those 
found in LNCaP cells. Thus disruption of the cAMP signal- 
ling pathway in androgen insensitive cell lines (DU-145 and 
PC-3) is not due to non-functioning CREB. A possible xpla- 
nation for our observation is that cAMP response is down 
regulated by heterodimer formation of CREB with activating 
transcription factor-1 [11]. Thus, only cells which contain a 
significant proportion of homodimeric CREB will be respon- 
sive. The loss of AR gene transcription via a second messen- 
ger pathway may be an important primary mechanism of 
androgen insensitivity in prostate cancer, 
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